Accuray Incorporated (ARAY) vs Baird Medical Investment Holdings Limited (BDMD)

A side-by-side comparison of Accuray Incorporated and Baird Medical Investment Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ARAY vs BDMD

growth of $100 · dividends reinvested · last 5y
ARAY -93.8% (-42.7%/yr)BDMD -92.3% (-40.1%/yr)BDMD compounded faster over this window
050100Start $10020222023202420252026$6$8
ARAY BDMD

ARAY vs BDMD: by the numbers

  • •ARAY is the larger company ($34M vs $31M market cap).
  • •Both run net losses; ARAY's is the smaller (-12.24% vs -121.04% net margin).
  • •BDMD grew revenue faster over the past five years (4.46% vs 0.28% CAGR).

Metrics side by side

Valuation

MetricARAYBDMD
Forward P/EN/A9.31
P/S ratio0.09N/A
P/B ratio0.830.90

Profitability

MetricARAYBDMD
Gross margin27.73%83.79%
Operating margin-6.58%-113.31%
Net margin-12.24%-121.04%
ROE-117.97%-86.96%
ROIC-10.09%-50.66%

Growth (annualized)

MetricARAYBDMD
Revenue CAGR (5Y)0.28%4.46%
Total return CAGR (5Y)-39.94%N/A

Frequently asked

Which has grown faster, ARAY or BDMD?
Over the past five years, BDMD grew revenue faster — ARAY at a 0.28% CAGR versus BDMD at 4.46%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.